about
Network analysis of gene expression in mice provides new evidence of involvement of the mTOR pathway in antipsychotic-induced extrapyramidal symptoms.SiNoPsis: Single Nucleotide Polymorphisms selection and promoter profiling.Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder.Microarray gene-expression study in fibroblast and lymphoblastoid cell lines from antipsychotic-naïve first-episode schizophrenia patients.Human-leukocyte antigen class II genes in early-onset obsessive-compulsive disorder.Association of regulatory TPH2 polymorphisms with higher reduction in depressive symptoms in children and adolescents treated with fluoxetine.Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients.Epigenetic and genetic variants in the HTR1B gene and clinical improvement in children and adolescents treated with fluoxetine.Pharmacogenetic study focused on fluoxetine pharmacodynamics in children and adolescent patients: impact of the serotonin pathway.Association of CACNA1C and SYNE1 in offspring of patients with psychiatric disorders.Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients.Role of GAD2 and HTR1B genes in early-onset obsessive-compulsive disorder: results from transmission disequilibrium study.Genetic Associations of Serotoninergic and GABAergic Genes in an Extended Collection of Early-Onset Obsessive-Compulsive Disorder TriosThe effect of age on DNA concentration from whole saliva: Implications for the standard isolation methodImproving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychoticsFurther Support for the Involvement of Genetic Variants Related to the Serotonergic Pathway in the Antidepressant Response in Children and Adolescents After a 12-Month Follow-Up: Impact of the HTR2A rs7997012 PolymorphismGenetic variability in the serotoninergic system and age of onset in anorexia nervosa and obsessive-compulsive disorderPersonalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohortAltered frequencies of Th17 and Treg cells in children and adolescents with obsessive-compulsive disorder
P50
Q38990216-E03CD6BB-1472-4A31-81F8-8382C4559EFEQ47316848-8FCB4F93-832B-4EF6-A1E3-2DE05D9D0262Q47560028-CCB10D67-323D-4054-8366-7C61A8E2D217Q47642710-18B626D8-3228-48CF-A641-732E9490FE7BQ47708238-E69A7E3D-58CB-405A-84DC-E130A19087DFQ47736432-A18866CD-C868-40BE-8708-1F7441709999Q47753890-AE79CA57-B698-495A-AD42-E85E35737446Q47843185-64942F43-50EB-4C07-8471-D9506DDC2E61Q47913959-6C5C8EF3-464D-419F-A04B-429A3D644350Q47940250-3FE745F0-2276-4F6D-917E-95A34C6A420CQ50475979-6A300712-4840-4EEC-95AB-20D2C1FE9498Q50478446-17586D1F-E660-4DEE-8637-F49792FABC81Q57797724-E8E3B198-D670-4DAF-AAE9-690F7B572969Q59539608-EB606D38-8EBD-4A90-87A1-720396014860Q60045127-C4B84BEC-D7F8-44A0-8BB0-74F92A9247DCQ89429724-92F78148-79F9-4EDA-B258-3971C4C8FDD6Q90560110-4D8568B1-AAFF-449B-8C78-1683A4F41013Q91351508-A0AC7C2D-745F-4473-B1AD-A817AF6719B1Q92175718-54C2CD68-9327-42C7-9165-3BCF23CE1368
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Natalia Rodriguez
@ast
Natalia Rodriguez
@en
Natalia Rodriguez
@es
Natalia Rodriguez
@nl
Natalia Rodriguez
@sl
type
label
Natalia Rodriguez
@ast
Natalia Rodriguez
@en
Natalia Rodriguez
@es
Natalia Rodriguez
@nl
Natalia Rodriguez
@sl
prefLabel
Natalia Rodriguez
@ast
Natalia Rodriguez
@en
Natalia Rodriguez
@es
Natalia Rodriguez
@nl
Natalia Rodriguez
@sl
P106
P21
P31
P496
0000-0002-9618-9383
P569
2000-01-01T00:00:00Z